Optical Devices for Monitoring Patient Glucose Levels - ResearchAndMarkets.com

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Sep 23, 2022 11:25 am
DUBLIN -- 

The "Optical Devices for Monitoring Patient Glucose Levels" report has been added to ResearchAndMarkets.com's offering.

Noninvasive monitors that can measure analyte levels accurately and reliably have the capability to improve disease control and patient wellbeing. By integrating the sensing element, electronics, and a power source in a single package, noninvasive monitors are creating new options for caregivers and their patients.

Signal processing improvements - include improved signal-to-noise ratios and interference filtering - will continue to be critical to the commercialization prospects of noninvasive monitors. For patient with chronic conditions monitoring is a way of life, Now the convergence of small-scale electronics and sophisticated biocompatible product designs is providing a better way to manage chronic conditions for patients worldwide.

Noninvasive monitors that can measure analyte levels accurately and reliably have the capability to improve disease control and patient wellbeing. By integrating the sensing element, electronics, and a power source in a single package, noninvasive monitors are creating new options for caregivers and their patients. Signal processing improvements - include improved signal-to-noise ratios and interference filtering - will continue to be critical to the commercialization prospects of noninvasive monitors.

Optical Devices for Monitoring Patient Glucose Levels - What You Will Learn

  • What are the noninvasive sensing and monitoring technologies that are being pursued, who are the players behind them, and what is their development status?
  • What are the key noninvasive optical monitoring device design issues and evolving market factors?
  • What is the global market potential for optical monitors today? What will it be in 2024?
  • What will be the likely impact of the availability of commercial noninvasive sensing technology and devices on disease management markets?
  • Who are the market participants in the noninvasive monitoring sector? What are their technologies, product development activities and business strategies?
  • What will be the impact of economic, technology, and regulatory factors on the commercial potential of optical device patient monitors?

Key Topics Covered:

  • Executive Summary
  • Glucose Sensing Market Overview
  • Monitoring Glucose Levels
  • Key Factors in Patient Compliance
  • Market Drivers
  • Industry Alignment and Competitive Landscape
  • Noninvasive Glucose Measurement Design Factors
  • Measuring Glucose in Interstitial Fluid
  • Patient/User Interface
  • Reliability
  • Data Collection & Reporting
  • Commercial Track NGM Technologies
  • Spectroscopy
  • Raman
  • Infrared
  • Reverse Iontophoresis
  • Continuous Glucose Monitoring
  • Near-term Noninvasive Glucose Measurement Device Analysis
  • Optical Data Collection
  • Direct Analyte Measurement
  • Multimode Sensing
  • Forecasts
  • Important Private Research Programs
  • Asia
  • Soompo Japan Research Institute
  • Toyama Medical And Pharmaceutical University (Japan)
  • North America
  • Juvenile Diabetes Research Foundation (USA)
  • Europe
  • Medical University of Graz (Austria)
  • Medical Research Foundation (The Netherlands)
  • Commercialization Factors
  • Calibration Frequency
  • Accuracy & Precision
  • Sensitivity
  • Sensor Technology & Signal Processing Advances
  • Market Factors
  • Regulations
  • FDA
  • EMEA
  • Asia (Japan)
  • Clinical Trials
  • Company Profiles

Companies Mentioned

  • Soompo Japan Research Institute
  • Toyama Medical And Pharmaceutical University (Japan)
  • Juvenile Diabetes Research Foundation (USA)
  • Medical University of Graz (Austria)
  • Medical Research Foundation (The Netherlands)

For more information about this report visit https://www.researchandmarkets.com/r/3y18m4

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).